Aleksandar Danilovski
Director/Board Member bij ACTIVE BIOTECH AB
Profiel
Aleksandar Danilovski is currently an Independent Director at Active Biotech AB and a Director at Pharmaero ApS.
He also serves as the Chief Scientific Officer at Xellia Pharmaceuticals ApS since 2009.
Previously, he held positions as a Principal at PLIVA, Inc., Head-European Research & Development at Barr Laboratories, Inc., and Member-Management Board at PLIVA Pharmaceuticals, Inc. He was also a Principal at The Barr Group, Inc. and a Member-Management Board at PLIVA Croatia Ltd.
from 2011 to 2012.
Additionally, he served as a Member-Scientific Selection Board at Novo Holdings A.
Danilovski obtained a doctorate degree from the University of Cambridge and holds undergraduate and doctorate degrees from the University of Zagreb.
Actieve functies van Aleksandar Danilovski
| Bedrijven | Functie | Begin |
|---|---|---|
| ACTIVE BIOTECH AB | Director/Board Member | 01-01-2020 |
Xellia Pharmaceuticals ApS
 Xellia Pharmaceuticals ApS Pharmaceuticals: MajorHealth Technology Xellia Pharmaceuticals ApS manufactures pharmaceutical products. Its products include pharmaceutical ingredients, finished dosage forms and novel anti infective pipeline. The company was founded in 1959 and is headquartered in Copenhagen, Denmark. | Chief Tech/Sci/R&D Officer | 01-01-2020 |
| Pharmaero ApS | Director/Board Member | - |
Eerdere bekende functies van Aleksandar Danilovski
| Bedrijven | Functie | Einde |
|---|---|---|
| PLIVA Pharmaceuticals, Inc. | Corporate Officer/Principal | - |
Barr Laboratories, Inc.
 Barr Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Barr Laboratories, Inc. develops and markets generic pharmaceuticals. The company was founded by Edwin A. Cohen in 1970 and is headquartered in Montvale, NJ. | Corporate Officer/Principal | - |
Novo Holdings A/S (Investment Company)
 Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings A/S (Investment Company) (Novo Holdings-IC) is the investment portfolio division of Novo Holdings A/S, a holding company headquartered in Hellerup, Denmark. They are ultimately owned by Novo Nordisk Fonden (Novo Nordisk Foundation). Founded in 1999, Novo Holdings-IC manages a broad portfolio of the Foundation’s financial assets. | Corporate Officer/Principal | - |
| PLIVA Croatia Ltd. | Director/Board Member | - |
| The Barr Group, Inc. | Corporate Officer/Principal | - |
Opleiding van Aleksandar Danilovski
| University of Cambridge | Doctorate Degree |
| University of Zagreb | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ACTIVE BIOTECH AB | Health Technology |
| Bedrijven in privébezit | 8 |
|---|---|
PLIVA, Inc.
 PLIVA, Inc. Drugstore ChainsRetail Trade PLIVA, Inc. develops, produces, and sells drugs and pharmaceutical products. Its products include Ethosuximide, Fluoxetine, and Cyclosporine. The company was founded in 1921 and is headquartered in East Hanover, NJ. | Retail Trade |
Barr Laboratories, Inc.
Barr Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Barr Laboratories, Inc. develops and markets generic pharmaceuticals. The company was founded by Edwin A. Cohen in 1970 and is headquartered in Montvale, NJ. | Health Technology |
| PLIVA Pharmaceuticals, Inc. | |
Xellia Pharmaceuticals ApS
Xellia Pharmaceuticals ApS Pharmaceuticals: MajorHealth Technology Xellia Pharmaceuticals ApS manufactures pharmaceutical products. Its products include pharmaceutical ingredients, finished dosage forms and novel anti infective pipeline. The company was founded in 1959 and is headquartered in Copenhagen, Denmark. | Health Technology |
| The Barr Group, Inc. | |
| PLIVA Croatia Ltd. | |
Novo Holdings A/S (Investment Company)
Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings A/S (Investment Company) (Novo Holdings-IC) is the investment portfolio division of Novo Holdings A/S, a holding company headquartered in Hellerup, Denmark. They are ultimately owned by Novo Nordisk Fonden (Novo Nordisk Foundation). Founded in 1999, Novo Holdings-IC manages a broad portfolio of the Foundation’s financial assets. | Finance |
| Pharmaero ApS |
